Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

SIG-1451 could be a promising new treatment for atopic dermatitis.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Upadacitinib may effectively treat resistant lichen planopilaris.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

QLT0267 stops hair follicle cell growth and movement.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The compound 4c showed strong potential as an anticancer agent.

Janus kinase inhibitors may help treat lichen planopilaris.

New compounds show promise as nonsteroidal treatments for hair loss.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.